News | April 07, 2025
Fluor to provide EPCM services for pharmaceutical facility in Indiana
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
Dyrupeg will be available as 6 mg solution for injection in prefilled syringe and is intended for the reduction in the duration of neutropenia
The company plans to fund this Capex through debt and internal accruals and expects the project to be completed by FY27
Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Jagsonpal Pharmaceuticals has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration formalities
Subscribe To Our Newsletter & Stay Updated
